BME100 f2016:Group14 W8AM L3
|BME 100 Fall 2016|| Home |
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Wiki Editing Help
LAB 3 WRITE-UP
Descriptive Stats and Graph
p value (Paired)= 0.427; No Significant Difference
Pearson's r= 0.644; No Significant Difference
p value (Paired)= 1.100E-21; Yes Significant Difference
Pearson's r= 0.193; Yes Significant Difference
CONCLUSION: The Spree Band is NOT accurate/precise for measuring temperature.
Experimental Design of Own Device
Hypothesis: Using a patch to administer ADHD medication and using currents to control dosage will be more efficient than consuming pills because the patch will promote consistency in dosage and easier use, since it is on the skin all day and steadily releases medication. The current will be beneficial because it will be synced with an app and allow subjects to disperse more of a controlled dosage when needed.
Experiment: In order to test the prototype we will conduct two experiments. In the first experiment group one will test people recently diagnosed with ADHD and no previous usage of ADHD medication on the patch for 60 days. This would be done to avoid bias samples because people who have already taken a form of ADHD medication could potentially favor that form of medication. A physician certified to diagnose ADHD will survey them before the experiment, one check-up at the 30 day mark, and immediately after the 60 day trial. The physician’s survey of patients will include concentration based tests at each check up. The second experiment will test people who have taken Adderall pills for their ADHD. The sample size for both experiments will be a group of 100 patients. This group will help decipher which form of ADHD medication patients prefer. The testing will follow the format of the first group. The physician will test the subjects, before the experiment, after 30 days, and at the end of the 60 days.